Subscribe to RSS - FDA


Sale helps to boost earnings at Invacare


ELYRIA, Ohio – Invacare’s third-quarter net earnings were $16.1 million for the quarter ended Sept. 30, compared to $2.9 million for the same time period last year, the company reported Oct. 24.

In brief: Phone calls improve compliance, provider runs for statehouse


BARCELONA, Spain – CPAP patients who received follow-up phone calls were 10% more compliant, according to a French study.

FDA finalizes device identification rule


WASHINGTON – The U.S. Food and Drug Administration (FDA)* released a final rule Sept. 20 that requires manufacturers to mark most medical devices distributed in the country with a unique device identifier (UDI).

New lawsuit claims Invacare slow to reveal troubles from employees


CLEVELAND – A former Invacare employee seeks class action status for a lawsuit she has filed against the company, alleging it failed to inform employees that it was in trouble with the U.S. Food and Drug Administration (FDA) over quality control procedures, Cleveland Business News reports.

Prodigy responds to FDA warning


CHARLOTTE, N.C. – Prodigy Diabetes Care has conducted a regulatory assessment by an independent auditor to examine, review and revise certain procedures and training to ensure compliance with FDA requirements, it told patients, caregivers and partners in a Sept. 4 letter.

Layoffs at Invacare hit 236


ELYRIA, Ohio – Invacare has laid off an additional 25 workers at its Taylor Street manufacturing facility.

Invacare clears second hurdle

Third and final audit will take longer than expected

ELYRIA, Ohio – Invacare announced today that the U.S. Food and Drug Administration (FDA) has approved the second of three audits, allowing the company to resume design activities for power wheelchairs and electric beds at its corporate and Taylor Street facilities.

Respironics recalls V60 vents


CARLSBAD, Calif. – Respironics California, a Philips Healthcare business, has announced that its worldwide recall of about 19,200 V60 ventilators has been designated a Class I recall by the U.S. Food and Drug Administration (FDA).

Another law firm launches Invacare probe


LOS ANGELES – The Law Offices of Todd M. Garber is investigating potential claims against Invacare concerning possible violations of federal securities laws related to the company’s problems with the Food and Drug Administration (FDA), according to a press release.

Law firms file class action lawsuits against Invacare


ELYRIA, Ohio – Two law firms have filed class action lawsuits against Invacare on behalf of investors who bought stock between July 22, 2010, and Dec. 7, 2011, according to press releases.